Lorente D, Llacer C, Lozano R, de Velasco G, et al. Prognostic Score and Benefit from Abiraterone in First-line Metastatic, Castration-resistant Prostate Cancer. Eur Urol 2021 Aug 6. pii: S0302-2838(21)01917.
PMID: 34373138